Pioneering Clinical Research for a Healthier African Future
Pioneering Clinical Research for a Healthier African Future
Pioneering Clinical Research for a Healthier African Future

WHO WE ARE

Synergy Biomed Research Institute (SBRI), a diverse black-and-women-led organisation, was established in 2020 in East London, South Africa, to address the critical need for clinical research capacity in the Eastern Cape province. Situated strategically in East London’s CBD, SBRI boasts a dedicated Research Team.

CorporateSession2024__160_Gen
getting-new-investigation-underway-portrait-young-scientist-using-microscope-lab-no-badge

WHAT WE DO

Specialising in clinical trials related to Infectious Diseases, Non-Communicable Diseases, and Paediatrics, SBRI has become a beacon of excellence with world class facilities, hoping to achieve our vision to be a renowned global player in clinical research, with a mission to expand into being a multi-faceted research centre priding itself on the highest quality standards.

THE NEED

In the Eastern Cape, health challenges persist at alarming rates. The region faces a complex health landscape.

SBRI was founded to bridge the research capacity gap in the region, aiming to tackle these challenges head-on through clinical trials and community engagement.

14% HIV prevalence

was recorded in the buffalo city metro in 2018

743 per 100 000

tb cases were reported in 2015

81% females

50 years and older are recorded for non-communicable diseases in the eastern cape

OUR SOLUTION

Our state-of-the-art facilities are designed to facilitate excellence in clinical trials. With a focus on building research capacity and fostering collaborations, SBRI aims to make a lasting impact on the health landscape of the region.

1J3A9397

OUR IMPACT

At SBRI, our diverse portfolio of clinical trials encompasses a range of global health concerns, including but not limited to, HIV, TB, Influenza, RSV and COVID-19.

top 5 recruiters

in all our trials to date

12 Advisory Board Members

as part of the community advisory board representing the buffalo city metro

2163 participants

enrolled across our current studies

SINCE 2020

of sbri within the buffalo city metro and east london community

95—100%

average retention rate for all trials

LATEST NEWS

Clinical Research

SBRI Welcomes a New Era in HIV Prevention

Our mission to serve our communities begins with supporting our own team. That’s why we are thrilled to announce the launch of the LYRA Wellbeing Programme at SBRI, a new

Read More

Home